Clinical Trials Browser

Phase 1 × OTHER × AVB-500 fusion protein × Clear all

NCT05826015 2024-10-02

AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Phase 1 Withdrawn

Recurrent High Grade Uterine Cancer